Read the Beforeitsnews.com story here. Advertise at Before It's News here.
Profile image
By Freedom Bunker
Contributor profile | More stories
Story Views
Now:
Last hour:
Last 24 hours:
Total:

What To Watch As SpaceX’s IPO Filing Drop Imminent

% of readers think this story is Fact. Add your two cents.


What To Watch As SpaceX’s IPO Filing Drop Imminent

Ahead of Thursday’s scheduled launch of SpaceX’s Starship V3 rocket, there are indications that Elon Musk’s rocket and AI company could release its IPO filing as soon as this afternoon, giving investors, analysts, and competitors a rare look inside the finances and ownership structure of Musk’s space empire.

On Tuesday, The Wall Street Journal reported that Goldman Sachs secured the lead-left role on SpaceX’s upcoming IPO, positioning it as the top banker on what could become one of the largest public offerings in history.

SpaceX is expected to seek a valuation of up to $2 trillion, raising an estimated $75 billion to help fuel its AI and Starship rocket-launch ambitions after merging with xAI and pursuing plans for orbital data centers.

The company confidentially filed IPO documents with the SEC in early April, and its public S-1 filing is expected at any moment today.

Last Friday, Reuters reported that the IPO is set for pricing on June 11, followed by a June 12 debut.

The ticker “SPCX” leads the Polymarket bet, “What will SpaceX’s public ticker be?” at 91% by lunchtime in New York.

Will SpaceX’s public ticker be another ticker?
Yes 91% · No 9%
View full market & trade on Polymarket

Elon Musk virtually attended a summit in Tel Aviv on Monday, where he said, “We’ve got to get the SpaceX IPO stuff going here pretty soon.” Those comments put a bid into AST SpaceMobile, EchoStar, and Rocket Lab.

Bloomberg’s Eric Johnson outlined what exactly to look for when the S1 drops:

  • The company, known formally as Space Exploration Technologies Corp., is expected to pick Nasdaq as its listing venue, which would set it up for potential inclusion in the Nasdaq 100.

  • The IPO filing could include key financial details like revenue and net income across its launch, Starlink and artificial intelligence businesses, as well as capital spending on key programs like its colossal Starship rocket.

  • key programs like its colossal Starship rocket * SpaceX’s filing is set to reveal the hierarchy of the banks running the deal. Goldman Sachs Group Inc. and Morgan Stanley are the lead firms, with Bank of America Corp., Citigroup Inc. and JPMorgan Chase & Co. also working on the transaction, people familiar with the matter have said.

  • SpaceX will list its largest shareholders, including Musk himself and Alphabet Inc.’s Google; its investors also include Valor Equity Partners, Sequoia and Andreessen Horowitz.

  • We should find out how voting control of the company will be set up. SpaceX is considering a dual-class share structure, people with knowledge of the plans have said, which could allow Musk to maintain control of the company even with a minority stake.

  • The filing likely won’t include information on the price range per share, number of shares offered, shares outstanding or precise shareholdings. Those usually come at the start of formal marketing, which could be as early as June 4, ahead of pricing as soon as June 11, Bloomberg News reported.

The Information’s Cory Weinberg published five charts making sense of the IPO numbers: 

1. SpaceX is expected to file its S-1 publicly as soon as tomorrow.

We’ve reviewed parts of the draft prospectus and tried to make sense of the numbers. Here are 5 charts that explain the company before the largest IPO in history goes live.

2. The company has accumulated $37 billion in losses over its 24-year history — larger than what the next 10 major loss-making tech IPOs *combined* had to disclose at their offerings.

3. SpaceX will tell investors it has $6.6 billion in ‘adjusted’ profit last year. Under standard accounting, it lost $4.9 billion. 

That gap between headline profit and actual profit is larger than at CoreWeave, Viasat, or Tesla.

4. Starlink dominates. The satellite internet business generated $11.4 billion in revenue last year — more than 7 leading publicly traded satellite communications operators combined.

5. The Space segment — SpaceX’s launch business — grew only 8% last year. That’s because about three-quarters of Falcon 9 launches were for internal Starlink missions rather than outside customers.

6. The AI segment (X plus xAI) grew 23% last year, compared to over 1,000% for Anthropic and nearly 300% for OpenAI. xAI was slowest-growing of the major AI labs.

View Weinberg’s report here

With SpaceX set to be the first out of the gates among the three giant tech IPOs, we can’t help but wonder how well the record high market will absorb such supply (and what will be sold to make room for it)…

Shares of Goldman Sachs and Morgan Stanley were up around 4% during the lunch hour. These banks are expected to be the lead managers on the IPO.

Tyler Durden Wed, 05/20/2026 – 13:45


Source: https://freedombunker.com/2026/05/20/what-to-watch-as-spacexs-ipo-filing-drop-imminent/


Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.


LION'S MANE PRODUCT


Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules


Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.



Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.


Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

MOST RECENT
Load more ...

SignUp

Login